|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Surawicz TS, Davis F, Freels S, Laws ER Jr
and Menck HR: Brain tumor survival: results from the National
Cancer Data Base. J Neurooncol. 40:151–160. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bondy ML, Scheurer ME, Malmer B, et al:
Brain tumor epidemiology: consensus from the Brain Tumor
Epidemiology Consortium. Cancer. 113:1953–1968. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chargari C, Moncharmont C, Levy A, et al:
Cancer stem cells, cornerstone of radioresistance and perspectives
for radiosensitization: glioblastoma as an example. Bull Cancer.
99:1153–1160. 2012.(In French).
|
|
5
|
Warda M, Kim HK, Kim N, Ko KS, Rhee BD and
Han J: A matter of life, death and diseases: mitochondria from a
proteomic perspective. Expert Rev Proteomics. 10:97–111. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Uchiumi T and Kang D: The role of
TFAM-associated proteins in mitochondrial RNA metabolism. Biochim
Biophys Acta. 1820:565–570. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng Z and Ristow M: Mitochondria and
metabolic homeostasis. Antioxid Redox Signal. Mar 28–2013.(Epub
ahead of print).
|
|
8
|
Li X, Zhang G, Luo F, et al:
Identification of aberrantly expressed miRNAs in rectal cancer.
Oncol Rep. 28:77–84. 2012.PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nikaki A, Piperi C and Papavassiliou AG:
Role of microRNAs in gliomagenesis: targeting miRNAs in
glioblastoma multiforme therapy. Expert Opin Investig Drugs.
21:1475–1488. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Phang JM and Liu W: Proline metabolism and
cancer. Front Biosci. 17:1835–1845. 2012. View Article : Google Scholar
|
|
12
|
Jin L, Wessely O, Marcusson E, Ivan C,
Calin G and Alahari SK: Pro-oncogenic factors miR-23b and miR-27b
are regulated by Her2/Neu, EGF, and TNFα in breast cancer. Cancer
Res. 73:2884–2889. 2013.PubMed/NCBI
|
|
13
|
Yoshida T, Azuma H, Aihara K, et al:
Vascular smooth muscle cell proliferation is dependent upon
upregulation of mitochondrial transcription factor A (mtTFA)
expression in injured rat carotid artery. Atherosclerosis.
178:39–47. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim AJ, Jee HJ, Song N, Kim M, Jeong SY
and Yun J: p21WAF1/C1P1 deficiency induces mitochondrial
dysfunction in HCT116 colon cancer cells. Biochem Biophys Res
Commun. 430:653–658. 2013.PubMed/NCBI
|
|
15
|
Han B, Izumi H, Yasuniwa Y, et al: Human
mitochondrial transcription factor A functions in both nuclei and
mitochondria and regulates cancer cell growth. Biochem Biophys Res
Commun. 408:45–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo J, Zheng L, Liu W, et al: Frequent
truncating mutation of TFAM induces mitochondrial DNA depletion and
apoptotic resistance in microsatellite-unstable colorectal cancer.
Cancer Res. 71:2978–2987. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ishteiwy RA, Ward TM, Dykxhoorn DM and
Burnstein KL: The microRNA -23b/-27b cluster suppresses the
metastatic phenotype of castration-resistant prostate cancer cells.
PLoS One. 7:e521062012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zaman MS, Thamminana S, Shahryari V, et
al: Inhibition of PTEN gene expression by oncogenic miR-23b-3p in
renal cancer. PLoS One. 7:e502032012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Geng J, Luo H, Pu Y, et al: Methylation
mediated silencing of miR-23b expression and its role in glioma
stem cells. Neurosci Lett. 528:185–189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Loftus JC, Ross JT, Paquette KM, et al:
miRNA expression profiling in migrating glioblastoma cells:
regulation of cell migration and invasion by miR-23b via targeting
of Pyk2. PLoS One. 7:e398182012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Han L, Zhang K, et al: VHL
regulates the effects of miR-23b on glioma survival and invasion
via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling. Neuro
Oncol. 14:1026–1036. 2012.PubMed/NCBI
|
|
22
|
Berg M and Soreide K: EGFR and downstream
genetic alterations in KRAS/BRAF and PI3K/AKT pathways in
colorectal cancer: implications for targeted therapy. Discov Med.
14:207–214. 2012.PubMed/NCBI
|
|
23
|
Papadimitrakopoulou V: Development of
PI3K/AKT/mTOR pathway inhibitors and their application in
personalized therapy for non-small-cell lung cancer. J Thorac
Oncol. 7:1315–1326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
De Luca A, Maiello MR, D’Alessio A,
Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT
signalling pathways: role in cancer pathogenesis and implications
for therapeutic approaches. Expert Opin Ther Targets. 16(Suppl 2):
S17–S27. 2012.PubMed/NCBI
|
|
25
|
Rietz A and Spiers J: The relationship
between the MMP system, adrenoceptors and phosphoprotein
phosphatases. Br J Pharmacol. 166:1225–1243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
